Portfolio company
adivo
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops species-specific therapeutic monoclonal antibodies for companion animals, primarily targeting cancer and inflammatory diseases in dogs and cats.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
PetMedix
PetMedix develops species-specific monoclonal antibody therapeutics for companion animals to treat chronic and terminal diseases in dogs and cats.
ScoutBio
The company develops monoclonal antibodies and gene therapies for pets to treat chronic diseases.
Animol Discovery
This biopharmaceutical company develops small molecule medicines for companion and production animals using artificial intelligence and DNA-encoded library technologies.
Gallant Therapeutics
This company develops mesenchymal stromal cell therapies for veterinary professionals to treat inflammatory diseases and promote tissue repair in cats and dogs.
Aratana
This company develops and commercialises biopharmaceutical medicines for dogs and cats to treat conditions including pain and inappetence for the veterinary market.
Avidicure
This biotechnology company develops multifunctional antibody therapies for cancer patients to activate immune responses while reducing toxicity.
Gallant
The company develops ready-to-use mesenchymal stromal cell therapies for veterinary professionals to treat inflammatory diseases and promote tissue repair in cats and dogs.
DeepScan Diagnostics
This company develops cell-free DNA blood tests for veterinarians to detect cancer and monitor treatment response in dogs.
